Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence
about
ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination.Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection.The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment.The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection.A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers.Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab.BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infectionEnhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
P2860
Q37687572-2213ECC1-A4F5-407B-9288-2F3E23E76A6BQ37709350-21BBB816-BF0A-41F7-8C87-A856F718785AQ37737549-A5A4D118-78CB-4AB2-8BD0-E89E025781CFQ40532348-DA937FF1-417F-4CBF-AFC3-6F53FB3FD5C3Q42323496-6973DB0C-CE27-4902-AE89-F117EB9CDE44Q45324456-B2CB66A5-BCCA-4C94-8302-EE9052012816Q47548194-A4CA18D1-65B4-4263-86B7-DA2E0FD7108CQ47558114-D8656479-36C4-4DB0-BD87-C6E95A4B3719Q55665338-C241B633-E4AC-421F-8ACF-55A64592FA0EQ56895711-691A3A53-CBC6-439D-BCB4-FEFFA6E00892Q58767527-7DE58625-6626-4006-A804-1D2E5C2DB078
P2860
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Type I and Type II Interferon ...... ction during Viral Persistence
@ast
Type I and Type II Interferon ...... ction during Viral Persistence
@en
type
label
Type I and Type II Interferon ...... ction during Viral Persistence
@ast
Type I and Type II Interferon ...... ction during Viral Persistence
@en
prefLabel
Type I and Type II Interferon ...... ction during Viral Persistence
@ast
Type I and Type II Interferon ...... ction during Viral Persistence
@en
P2093
P2860
P1433
P1476
Type I and Type II Interferon ...... ction during Viral Persistence
@en
P2093
Ameya Champhekar
Anjie Zhen
Barbara Jane Dillon
Cameron R Cunningham
David G Brooks
Elizabeth B Wilson
Heidi Elsaesser
Jonathan Herskovitz
Juan Carlos de la Torre
Justin Rafael de la Fuente
P2860
P304
P356
10.1371/JOURNAL.PPAT.1005356
P577
2016-01-25T00:00:00Z